Neurocrine Biosciences, Inc.NBIXNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$639.70M
↑ 357% above average
Average (9y)
$140.06M
Historical baseline
Range
High:$639.70M
Low:$-139.64M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $639.70M | +53.7% |
| 2023 | $416.10M | +57.3% |
| 2022 | $264.60M | +91.6% |
| 2021 | $138.10M | -6.8% |
| 2020 | $148.10M | +72.4% |
| 2019 | $85.90M | +52.6% |
| 2018 | $56.30M | +146.7% |
| 2017 | $-120.62M | +13.6% |
| 2016 | $-139.64M | -58.8% |
| 2015 | $-87.92M | - |